Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Asian Pacific Journal of Cancer Prevention : APJCP|September 1, 2015
Selective Radiotherapy after Distant Metastasis of Nasopharyngeal Carcinoma Treated with Dose-Dense Cisplatin plus FluorouracilYong Liang, Jun-Guo Bu, Jin-Ling Cheng, et al.Acta Pharmacologica Sinica|June 20, 2024
Structural basis of tolvaptan binding to the vasopressin V2 receptorHong-Li Liu, Hai-Yang Zhong, Yi-Xiao Zhang, et al.Annals of Surgical Oncology|November 17, 2004
Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinomaFeng Wu, Zhi-Biao Wang, Wen-Zhi Chen, et al.Scientific Reports|March 30, 2024
Prevalence of common autosomal recessive mutation carriers in women in the Southern Vietnam following the application of expanded carrier screeningXuan-Hong To-Mai, Huu-Trung Nguyen, Thanh-Truc Nguyen-Thi, et al.Radiology|April 29, 2005
Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolizationFeng Wu, Zhi-Biao Wang, Wen-Zhi Chen, et al.Radiology|August 2, 2005
Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experienceFeng Wu, Zhi-Biao Wang, Hui Zhu, et al.Breast Cancer Research and Treatment|June 28, 2005
Extracorporeal high intensity focused ultrasound treatment for patients with breast cancerFeng Wu, Zhi-Biao Wang, Hui Zhu, et al.Ultrasound in Medicine & Biology|March 5, 2004
Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experienceFeng Wu, Zhi-Biao Wang, Wen-Zhi Chen, et al.Ultrasound in Medicine & Biology|November 5, 2003
Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasoundFeng Wu, Zhi-Biao Wang, You-De Cao, et al.Journal of Medicinal Chemistry|May 8, 2026
Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer ImmunotherapyZhiyuan Cheng, Jiacheng He, Changyao Li, et al.Pageof 10